Scientists train Patients' own cells to fight lung cancer
NCT ID NCT06455917
Summary
This trial tests whether a personalized immune cell therapy can help control advanced lung cancer in patients who have exhausted standard treatments. Doctors collect immune cells from each patient's tumor, grow large numbers of them in the lab, and then infuse them back into the patient. The study will measure whether this approach can stop cancer progression for at least 6 months and evaluate its safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Medical Oncology, University Hospital Basel
RECRUITINGBasel, Canton of Basel-City, 4031, Switzerland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.